Aquatic Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,500
| Closed | -$472K | – | 1441 |
|
|
2024
Q2 | $472K | Sell |
16,500
-6,700
| -29% | -$192K | 0.02% | 549 |
|
|
2024
Q1 | $678K | Buy |
23,200
+17,600
| +314% | +$514K | 0.02% | 478 |
|
|
2023
Q4 | $189K | Buy |
5,600
+700
| +14% | +$23.6K | ﹤0.01% | 861 |
|
|
2023
Q3 | $150K | Sell |
4,900
-100
| -2% | -$3.06K | 0.01% | 743 |
|
|
2023
Q2 | $200K | Buy |
5,000
+4,600
| +1,150% | +$184K | 0.01% | 667 |
|
|
2023
Q1 | $16K | Sell |
400
-19,100
| -98% | -$764K | ﹤0.01% | 1075 |
|
|
2022
Q4 | $753K | Buy |
19,500
+19,300
| +9,650% | +$745K | 0.06% | 395 |
|
|
2022
Q3 | $11K | Hold |
200
| – | – | ﹤0.01% | 1049 |
|
|
2022
Q2 | $12K | Buy |
+200
| New | +$12K | ﹤0.01% | 939 |
|